高危个体胰腺癌MRI监测的性能评估
单中心回顾性研究纳入274例前瞻性收集的胰腺癌高危个体(2002-2023年),2010年起仅用MRI监测。中位随访5.8年,胰腺癌发生率为0.32/100人年,I期与IV期比例相近,未发现高级别异型增生病变。MRI监测敏感度67%、特异度98%、阳性预测值44%、阴性预测值99%。
要点
- 高危个体胰腺癌MRI监测敏感度67%、阳性预测值44%,早期诊断具挑战性。
- 胰腺癌发生率低(0.32/100人年),I期与IV期比例相近,未发现高级别异型增生病变。
- MRI监测特异度98%、阴性预测值99%,阴性结果排除价值高。
核心结论
- 高危个体胰腺癌发生率为0.32/100人年,I期与IV期胰腺癌比例相近,未发现高级别异型增生病变。
- MRI监测敏感度67%、阳性预测值44%均较低,提示在MRI监测背景下早期诊断胰腺癌具有挑战性。
研究设计与样本
- 单中心回顾性研究,纳入274例前瞻性收集的胰腺癌高危个体,时间跨度为2002年至2023年。
- 2010年起监测仅采用MRI,2002-2009年采用MRI和/或CT。
- 记录MRI表现、人口学、临床及组织病理学数据,计算监测项目的诊断准确性指标。
关键影像表现/征象
- 59%的患者检出局灶性病变:囊性病变56%(152/274)、囊实性病变3%(8/274)、实性病变1%(2/274)。
- 4例(1%,4/274)有可疑囊性病变,其中3例切除,组织病理学未发现高级别异型增生。
- 6例(2%,6/274)发生胰腺癌:I期2例(0.7%)、II期1例(0.4%)、IV期3例(1.1%)。
- 6例胰腺癌患者中3例在诊断时已有肝转移。
诊断标准与关键数值
- MRI监测诊断准确性:敏感度67%(95%CI 22-96%),特异度98%(95%CI 96-99%)。
- 阳性预测值44%(95%CI 14-79%),阴性预测值99%(95%CI 97-99%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Surveillance is recommended in high-risk individuals (HRIs) for pancreatic cancer (PC), as it seems effective in detecting malignant/premalignant lesions. Most surveillance programs are based on a combination of MRI and endoscopic ultrasound. This study aimed to evaluate the incidence of relevant imaging findings (PC and lesions with high-grade dysplasia) and the performance of MRI-based surveillance in a single-centre HRIs cohort.
METHODS: Single-centre, retrospective study on 274 prospectively collected HRIs (2002-2023). Surveillance was performed exclusively with MRI from 2010; MRI and/or CT in 2002-2009. MRI findings, demographic, clinical, and histopathological data were recorded. Diagnostic accuracy measures for the surveillance program were calculated.
RESULTS: The median follow-up was 5.8 years. Focal lesions were detected in 59 % of the patients: cysts in 56 % (152/274), cystic and solid lesions in 3 % (8/274), and solid lesions in 1 % (2/274). Four patients (1 %, 4/274) had suspicious cysts (3 resected; no high-grade dysplasia at histopathology). Six patients (2 %; 6/274) had PC: two in stage I (0.7 %), one in stage II (0.4 %), three in stage IV (1.1 %). Three out of six patients had liver metastases at diagnosis. Surveillance diagnostic accuracy measures: sensitivity 67 % (95 %CI 22-96 %), specificity 98 % (95 %CI 96-99 %), positive predictive value (PPV) 44 % (95 %CI 14-79 %), negative predictive value 99 % (95 %CI 97-99 %).
CONCLUSIONS: The incidence of PC in HRIs was low (0.32 per 100-person-years), with similar proportion of stage I and IV PC. No lesions with high-grade dysplasia were identified. Sensitivity and PPV were low, suggesting that early diagnosis of PC in MRI surveillance setting is challenging. Keywords (Mesh terms) Pancreas, Pancreatic Cancer, Early Diagnosis, Surveillance, MRI, Incidence.
引用
- Pozzi Mucelli RM, Vujasinovic M, Farah-Mwais A, et al. Performance of MRI-based surveillance for high-risk individuals for pancreatic cancer. Eur J Radiol. 2025. PMID: 40651113. doi:10.1016/j.ejrad.2025.112275
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。